MOOD Stock Overview
Through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of nutraceutical products in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Doseology Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.15 |
| 52 Week High | CA$0.66 |
| 52 Week Low | CA$0.07 |
| Beta | 0 |
| 1 Month Change | -40.00% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 3 Year Change | -90.32% |
| 5 Year Change | n/a |
| Change since IPO | -94.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MOOD | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | 0% | 3.5% | -3.7% |
| 1Y | 0% | 6.6% | 15.0% |
Return vs Industry: MOOD underperformed the Canadian Personal Products industry which returned 6.6% over the past year.
Return vs Market: MOOD underperformed the Canadian Market which returned 15% over the past year.
Price Volatility
| MOOD volatility | |
|---|---|
| MOOD Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 10.9% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: MOOD's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine MOOD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | Christopher Cherry | doseology.com |
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of nutraceutical products in Canada. The company offers medicinal mushroom products, including tinctures, powders, and herbal supplements to enhance health with a focus on mental health. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors.
Doseology Sciences Inc. Fundamentals Summary
| MOOD fundamental statistics | |
|---|---|
| Market cap | CA$660.08k |
| Earnings (TTM) | CA$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MOOD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOOD income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$0 |
| Earnings | CA$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MOOD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 18:18 |
| End of Day Share Price | 2024/12/13 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Doseology Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|